Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Cho

Showing results (1531-1540 of 1,679) with videos related to

Pageof 168
Sort By:
Histopathology|November 17, 2015
Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implicationsJi Y Joung, Tae H Kim, Dae J Jeong, et al.
Cancer|September 11, 2020
ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group studyJames I Geller, Joseph G Pressey, Malcolm A Smith, et al.
Biological Psychiatry|May 19, 2020
MEF2C Hypofunction in Neuronal and Neuroimmune Populations Produces MEF2C Haploinsufficiency Syndrome-like Behaviors in MiceAdam J Harrington, Catherine M Bridges, Stefano Berto, et al.
Clinical and Translational Science|October 28, 2016
Exploration of Biomarkers for Amoxicillin/Clavulanate-Induced Liver Injury: Multi-Omics ApproachesJ Lee, S C Ji, B Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2009
Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4Costas A Lyssiotis, Ruth K Foreman, Judith Staerk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology GroupSuman Malempati, Brenda Weigel, Ashish M Ingle, et al.
The British Journal of Radiology|October 24, 2012
Dosimetric advantages of generalised equivalent uniform dose-based optimisation on dose-volume objectives in intensity-modulated radiotherapy planning for bilateral breast cancerT-F Lee, H-M Ting, P-J Chao, et al.
Oncology Reports|December 29, 1998
Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vectorJ H Kim, S J Gong, N C Yoo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 8, 2010
Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Cancer CohortKwang-Pil Ko, Sue K Park, Boyoung Park, et al.
JMIR Formative Research|December 22, 2022
Digital Medicine System in Veterans With Severe Mental Illness: Feasibility and Acceptability StudySarah Gonzales, Olaoluwa O Okusaga, J Corey Reuteman-Fowler, et al.
Pageof 168

Showing results (1531-1540 of 1,679) with videos related to

Sort By:
Pageof 168
Histopathology|November 17, 2015
Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implicationsJi Y Joung, Tae H Kim, Dae J Jeong, et al.
Cancer|September 11, 2020
ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group studyJames I Geller, Joseph G Pressey, Malcolm A Smith, et al.
Biological Psychiatry|May 19, 2020
MEF2C Hypofunction in Neuronal and Neuroimmune Populations Produces MEF2C Haploinsufficiency Syndrome-like Behaviors in MiceAdam J Harrington, Catherine M Bridges, Stefano Berto, et al.
Clinical and Translational Science|October 28, 2016
Exploration of Biomarkers for Amoxicillin/Clavulanate-Induced Liver Injury: Multi-Omics ApproachesJ Lee, S C Ji, B Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2009
Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4Costas A Lyssiotis, Ruth K Foreman, Judith Staerk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology GroupSuman Malempati, Brenda Weigel, Ashish M Ingle, et al.
The British Journal of Radiology|October 24, 2012
Dosimetric advantages of generalised equivalent uniform dose-based optimisation on dose-volume objectives in intensity-modulated radiotherapy planning for bilateral breast cancerT-F Lee, H-M Ting, P-J Chao, et al.
Oncology Reports|December 29, 1998
Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vectorJ H Kim, S J Gong, N C Yoo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 8, 2010
Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Cancer CohortKwang-Pil Ko, Sue K Park, Boyoung Park, et al.
JMIR Formative Research|December 22, 2022
Digital Medicine System in Veterans With Severe Mental Illness: Feasibility and Acceptability StudySarah Gonzales, Olaoluwa O Okusaga, J Corey Reuteman-Fowler, et al.
Pageof 168